- Jul 30, 2020
Hearing loss linked to neurocognitive deficits in childhood cancer survivors
Research shows that severe hearing loss in childhood cancer survivors is associated with neurocognitive deficits independent of type of therapy. Read more: https://www.eurekalert.org/pub_releases/2020-07/sjcr-jbp072820.php
- Jul 24, 2020
New drug may provide hope for children with untreatable cancers
"The experimental drug, known as 9-ING-4, targets a specific protein that seems to be active in many different types of cancer." Read more: https://turnto10.com/features/health-landing-page/new-drug-may-provide-hope-for-children-with-untreatable-cancers
- Jul 21, 2020
UM researchers find new targets for deadly children’s brain tumour
After discovering how a specific gene fuels a deadly form of children’s brain tumour, University of Manitoba researchers have successfully decreased this cancer in mice. Read more: https://news.umanitoba.ca/um-researchers-find-new-targets-for-deadly-childrens-brain-tumour/
- Jul 16, 2020
Finding hints at novel target for Ewing sarcoma therapy
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature. Read more: https://www.eurekalert.org/pub_releases/2020-07/uoth-fha071620.php#
- Jul 13, 2020
Scientists discover way to stop spread of devastating childhood cancer
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to "kinder" treatments for children with bone cancer, and save lives. Read more: https://medicalxpress.com/news/2020-07-scientists-devastating-childhood-cancer.html
- Jul 13, 2020
Despite treatment advances, ‘much to improve upon’ in high-risk neuroblastoma
As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key, according to Giselle Sholler, MD. Read more: https://www.healio.com/news/hematology-oncology/20200709/despite-treatment-advances-much-to-improve-upon-in-highrisk-neuroblastoma
- Jul 10, 2020
Monitoring for breast cancer after childhood chest radiation: When and how?
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress. Read more: https://www.eurekalert.org/pub_releases/2020-07/bch-mfb070820.php
- Jul 6, 2020
Rituximab Regimen Improves Survival in Children With Aggressive B-Cell Lymphoma
Adding rituximab (Rituxan, Truxima) to chemotherapy may be a new standard for treating children and young adults newly diagnosed with aggressive B-cell lymphoma, according to findings from a randomized, international, phase 3 trial. Read more: https://www.ajmc.com/newsroom/rituximab-regimen-improves-survival-in-children-with-aggressive-bcell-lymphoma